References
- Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45. 10.1016/j.radonc.2004.12.015
- Viswanathan AN, Creutzberg CL, Craighead P, McCormack M, Toita T, Narayan K, et al. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys 2012; 82: 250-5. 10.1016/j.ijrobp.2010.10.030
- Potter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100: 116-23. 10.1016/j.radonc.2011.07.012
- Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol 2014; 135: 231-8. 10.1016/j.ygyno.2014.08.027
- Potter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60. 10.1016/j.ctro.2018.01.001
- Mohamed S, Kallehauge J, Fokdal L, Lindegaard JC, Tanderup K. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy. Brachytherapy 2015; 14: 23-8. 10.1016/j.brachy.2014.09.010
- Marnitz S, Kohler C, Burova E, Wlodarczyk W, Jahn U, Grun A, et al. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity. Int J Radiat Oncol Biol Phys 2012; 82: e137-43. 10.1016/j.ijrobp.2010.10.066
- Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77. 10.1016/j.radonc.2005.11.014
- Hinz A, Singer S, Brahler E. European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol 2014; 53: 958-65. 10.3109/0284186x.2013.879998
- Lee Y, Lim MC, Kim SI, Joo J, Lee DO, Park SY. Comparison of quality of life and sexuality between cervical cancer survivors and healthy women. Cancer Res Treat 2016; 48: 1321-9. 10.4143/crt.2015.425
- Park SY, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer 2007; 110: 2716-25. 10.1002/cncr.23094
- Weaver KE, Forsythe LP, Reeve BB, Alfano CM, Rodriguez JL, Sabatino SA, et al. Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Pre 2012; 21: 2108-17. 10.1158/1055-9965.EPI-12-0740
- Kirchheiner K, Potter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petric P, et al. Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2016; 94: 1088-98. 10.1016/j.ijrobp.2015.12.363
- Kim Y, Kim YJ, Kim JY, Lim YK, Jeong C, Jeong J, et al. Toxicities and dosevolume histogram parameters of MRI-based brachytherapy for cervical cancer. Brachytherapy 2017; 16: 116-25. 10.1016/j.brachy.2016.10.005
- Mazeron R, Maroun P, Castelnau-Marchand P, Dumas I, del Campo ER, Cao K, et al. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: dose-volume effect relationships for the rectum and bladder. Radiother Oncol 2015; 116: 226-32. 10.1016/j.radonc.2015.06.027
- Foerster R, Schnetzke L, Bruckner T, Arians N, Rief H, Debus J, et al. Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer. Strahlenther Onkol 2016; 192: 895-904. 10.1007/s00066-016-1037-1
- Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001; 61: 223-31. 10.1016/S0167-8140(01)00429-7
- Rajasooriyar C, Van Dyk S, Lindawati M, Bernshaw D, Kondalsamy-Chennakesavan S, Narayan K. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography. Int J Gynecol Cancer 2012; 22: 1532-7. 10.1097/IGC.0b013e31826c4dee
- Huang EY, Lin H, Hsu HC, Wang CJ, Chen HC, Sun LM, et al. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol 2000; 79: 406-10. 10.1006/gyno.2000.5997
- Huang EY, Wang CJ, Hsu HC, Hao L, Chen HC, Sun LM. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose. Gynecol Oncol 2004; 95: 101-8. 10.1016/j.ygyno.2004.06.043
- Fenkell L, Assenholt M, Nielsen SK, Haie-Meder C, Potter R, Lindegaard J, et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2011; 79: 1572-9. 10.1016/j.ijrobp.2010.05.031
- Boyle J, Craciunescu O, Steffey B, Cai J, Chino J. Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies. Gynecol Oncol 2014; 135: 239-43. 10.1016/j.ygyno.2014.08.037
- Sturdza A, Potter R, Fokdal LU, Haie-Meder C, Tan LT, Mazeron R, et al. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-33. 10.1016/j.radonc.2016.03.011
- Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, et al. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2014; 89: 88-95. 10.1016/j.ijrobp.2014.01.032
- Kirchheiner K, Nout RA, Lindegaard JC, Haie-Meder C, Mahantshetty U, Segedin B, et al. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol 2016; 118: 160-6. 10.1016/j.radonc.2015.12.025
- Mohamed S, Lindegaard JC, de Leeuw AA, Jurgenliemk-Schulz I, Kirchheiner K, Kirisits C, et al. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol 2016; 120: 480-5. 10.1016/j.radonc.2016.05.020
- Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43. 10.1056/nejm199904153401501
- Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53. 10.1056/nejm199904153401502
- Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, et al. Clinical outcome and dosimetric parameters of chemoradiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience. Radiother Oncol 2013; 107: 69-74. 10.1016/j.radonc.2013.04.006
- Fokdal L, Sturdza A, Mazeron R, Haie-Meder C, Tan LT, Gillham C, et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol 2016; 120: 434-40. 10.1016/j.radonc.2016.03.020